NSCLC cells treated with IS and IR results in the inhibition of proliferation and the induction of apoptosis by increasing/decreasing apoptosis-related protein expression via inactivation of IR-induced-NF-κB and activation of IR-induced-interleukin (IL)-13 signaling pathways. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.